Cargando…

Minimal clinically important decline in physical function over one year: EPOSA study

BACKGROUND: The Australian/Canadian hand Osteoarthritis Index (AUSCAN) and the Western Ontario and McMaster Universities knee and hip Osteoarthritis Index (WOMAC) are the most commonly used clinical tools to manage and monitor osteoarthritis (OA). Few studies have as yet reported longitudinal change...

Descripción completa

Detalles Bibliográficos
Autores principales: Siviero, Paola, Limongi, Federica, Gesmundo, Antonella, Zambon, Sabina, Cooper, Cyrus, Dennison, Elaine M., Edwards, Mark H., Timmermans, Erik J., van der Pas, Suzan, Schaap, Laura A., van Schoor, Natasja M., Denkinger, Michael D., Herbolsheimer, Florian, Peter, Richard, Castell, Maria Victoria, Otero, Ángel, Queipo, Rocio, Pedersen, Nancy L., Deeg, Dorly J. H., Maggi, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525447/
https://www.ncbi.nlm.nih.gov/pubmed/31101033
http://dx.doi.org/10.1186/s12891-019-2593-1
_version_ 1783419731502432256
author Siviero, Paola
Limongi, Federica
Gesmundo, Antonella
Zambon, Sabina
Cooper, Cyrus
Dennison, Elaine M.
Edwards, Mark H.
Timmermans, Erik J.
van der Pas, Suzan
Schaap, Laura A.
van Schoor, Natasja M.
Denkinger, Michael D.
Herbolsheimer, Florian
Peter, Richard
Castell, Maria Victoria
Otero, Ángel
Queipo, Rocio
Pedersen, Nancy L.
Deeg, Dorly J. H.
Maggi, Stefania
author_facet Siviero, Paola
Limongi, Federica
Gesmundo, Antonella
Zambon, Sabina
Cooper, Cyrus
Dennison, Elaine M.
Edwards, Mark H.
Timmermans, Erik J.
van der Pas, Suzan
Schaap, Laura A.
van Schoor, Natasja M.
Denkinger, Michael D.
Herbolsheimer, Florian
Peter, Richard
Castell, Maria Victoria
Otero, Ángel
Queipo, Rocio
Pedersen, Nancy L.
Deeg, Dorly J. H.
Maggi, Stefania
author_sort Siviero, Paola
collection PubMed
description BACKGROUND: The Australian/Canadian hand Osteoarthritis Index (AUSCAN) and the Western Ontario and McMaster Universities knee and hip Osteoarthritis Index (WOMAC) are the most commonly used clinical tools to manage and monitor osteoarthritis (OA). Few studies have as yet reported longitudinal changes in the AUSCAN index regarding the hand. While there are published data regarding WOMAC assessments of the hip and the knee, the two sites have always evaluated separately. The current study therefore sought to determine the minimal clinically important difference (MCID) in decline in the AUSCAN hand and WOMAC hip/knee physical function scores over 1 year using anchor-based and distribution-based methods. METHODS: The study analysed data collected by the European Project on Osteoarthritis, a prospective observational study investigating six adult cohorts with and without OA by evaluating changes in the AUSCAN and WOMAC physical function scores at baseline and 12–18 months later. Pain and stiffness scores, the performance-based grip strength and walking speed and health-related quality of life measures were used as the study’s anchors. Receiver operating characteristic curves and distribution-based methods were used to estimate the MCID in the AUSCAN and WOMAC physical function scores; only the data of those participants who possessed paired (baseline and follow up-measures) AUSCAN and WOMAC scores were included in the analysis. RESULTS: Out of the 1866 participants who were evaluated, 1842 had paired AUSCAN scores and 1845 had paired WOMAC scores. The changes in the AUSCAN physical function score correlated significantly with those in the AUSCAN pain score (r = 0.31). Anchor- and distribution-based approaches converged identifying 4 as the MCID for decline in the AUSCAN hand physical function. Changes in the WOMAC hip/knee physical function score were significantly correlated with changes in both the WOMAC pain score (r = 0.47) and the WOMAC stiffness score (r = 0.35). The different approaches converged identifying two as the MCID for decline in the WOMAC hip/knee physical function. CONCLUSIONS: The most reliable MCID estimates of decline over 1 year in the AUSCAN hand and WOMAC hip/knee physical function scores were 4 and 2 points, respectively.
format Online
Article
Text
id pubmed-6525447
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65254472019-05-24 Minimal clinically important decline in physical function over one year: EPOSA study Siviero, Paola Limongi, Federica Gesmundo, Antonella Zambon, Sabina Cooper, Cyrus Dennison, Elaine M. Edwards, Mark H. Timmermans, Erik J. van der Pas, Suzan Schaap, Laura A. van Schoor, Natasja M. Denkinger, Michael D. Herbolsheimer, Florian Peter, Richard Castell, Maria Victoria Otero, Ángel Queipo, Rocio Pedersen, Nancy L. Deeg, Dorly J. H. Maggi, Stefania BMC Musculoskelet Disord Research Article BACKGROUND: The Australian/Canadian hand Osteoarthritis Index (AUSCAN) and the Western Ontario and McMaster Universities knee and hip Osteoarthritis Index (WOMAC) are the most commonly used clinical tools to manage and monitor osteoarthritis (OA). Few studies have as yet reported longitudinal changes in the AUSCAN index regarding the hand. While there are published data regarding WOMAC assessments of the hip and the knee, the two sites have always evaluated separately. The current study therefore sought to determine the minimal clinically important difference (MCID) in decline in the AUSCAN hand and WOMAC hip/knee physical function scores over 1 year using anchor-based and distribution-based methods. METHODS: The study analysed data collected by the European Project on Osteoarthritis, a prospective observational study investigating six adult cohorts with and without OA by evaluating changes in the AUSCAN and WOMAC physical function scores at baseline and 12–18 months later. Pain and stiffness scores, the performance-based grip strength and walking speed and health-related quality of life measures were used as the study’s anchors. Receiver operating characteristic curves and distribution-based methods were used to estimate the MCID in the AUSCAN and WOMAC physical function scores; only the data of those participants who possessed paired (baseline and follow up-measures) AUSCAN and WOMAC scores were included in the analysis. RESULTS: Out of the 1866 participants who were evaluated, 1842 had paired AUSCAN scores and 1845 had paired WOMAC scores. The changes in the AUSCAN physical function score correlated significantly with those in the AUSCAN pain score (r = 0.31). Anchor- and distribution-based approaches converged identifying 4 as the MCID for decline in the AUSCAN hand physical function. Changes in the WOMAC hip/knee physical function score were significantly correlated with changes in both the WOMAC pain score (r = 0.47) and the WOMAC stiffness score (r = 0.35). The different approaches converged identifying two as the MCID for decline in the WOMAC hip/knee physical function. CONCLUSIONS: The most reliable MCID estimates of decline over 1 year in the AUSCAN hand and WOMAC hip/knee physical function scores were 4 and 2 points, respectively. BioMed Central 2019-05-17 /pmc/articles/PMC6525447/ /pubmed/31101033 http://dx.doi.org/10.1186/s12891-019-2593-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Siviero, Paola
Limongi, Federica
Gesmundo, Antonella
Zambon, Sabina
Cooper, Cyrus
Dennison, Elaine M.
Edwards, Mark H.
Timmermans, Erik J.
van der Pas, Suzan
Schaap, Laura A.
van Schoor, Natasja M.
Denkinger, Michael D.
Herbolsheimer, Florian
Peter, Richard
Castell, Maria Victoria
Otero, Ángel
Queipo, Rocio
Pedersen, Nancy L.
Deeg, Dorly J. H.
Maggi, Stefania
Minimal clinically important decline in physical function over one year: EPOSA study
title Minimal clinically important decline in physical function over one year: EPOSA study
title_full Minimal clinically important decline in physical function over one year: EPOSA study
title_fullStr Minimal clinically important decline in physical function over one year: EPOSA study
title_full_unstemmed Minimal clinically important decline in physical function over one year: EPOSA study
title_short Minimal clinically important decline in physical function over one year: EPOSA study
title_sort minimal clinically important decline in physical function over one year: eposa study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525447/
https://www.ncbi.nlm.nih.gov/pubmed/31101033
http://dx.doi.org/10.1186/s12891-019-2593-1
work_keys_str_mv AT sivieropaola minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT limongifederica minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT gesmundoantonella minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT zambonsabina minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT coopercyrus minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT dennisonelainem minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT edwardsmarkh minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT timmermanserikj minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT vanderpassuzan minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT schaaplauraa minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT vanschoornatasjam minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT denkingermichaeld minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT herbolsheimerflorian minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT peterrichard minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT castellmariavictoria minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT oteroangel minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT queiporocio minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT pedersennancyl minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT deegdorlyjh minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT maggistefania minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy
AT minimalclinicallyimportantdeclineinphysicalfunctionoveroneyeareposastudy